Abstract Background Chemotherapies used for the treatment of primary brain tumors frequently induce hematological toxicity. Thrombocytopenia represents main cause stopping chemotherapy Here we explored incidence, and consequences exposure survival, thrombocytopenia induced by lomustine at first recurrence glioblastoma. Methods We performed a retrospective analysis glioblastoma, its delivery, as...
